HomeNGENF • OTCMKTS
add
NervGen Pharma Corp
Previous close
$2.17
Day range
$2.05 - $2.15
Year range
$1.17 - $2.99
Market cap
200.08M CAD
Avg Volume
105.95K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 4.97M | 5.36% |
Net income | -2.35M | 50.19% |
Net profit margin | — | — |
Earnings per share | -0.04 | — |
EBITDA | -4.95M | -5.81% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 30.30M | 68.15% |
Total assets | 31.78M | 66.42% |
Total liabilities | 12.96M | 40.55% |
Total equity | 18.83M | — |
Shares outstanding | 69.93M | — |
Price to book | 8.03 | — |
Return on assets | -55.19% | — |
Return on capital | -144.55% | — |
Cash Flow
Net change in cash
(CAD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -2.35M | 50.19% |
Cash from operations | -3.25M | 32.09% |
Cash from investing | — | — |
Cash from financing | 22.00M | 5,924.01% |
Net change in cash | 18.64M | 520.86% |
Free cash flow | -4.12M | -35.58% |
About
Founded
2017
Headquarters
Website
Employees
10